Incannex Healthcare (IXHL) Goodwill & Intangibles (2022 - 2023)
Incannex Healthcare (IXHL) posted quarterly Goodwill & Intangibles of $52.7 million for Q2 2023, little changed on a QoQ basis from $52.7 million in Q4 2022.
Incannex Healthcare (IXHL) Goodwill & Intangibles (2022 - 2023) Analysis & Trends
Incannex Healthcare (IXHL) has reported Goodwill & Intangibles for 2 consecutive years, with $52.7 million the latest figure, recorded in Q2 2023.
- Quarterly Goodwill & Intangibles changed N/A year-over-year to $52.7 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $52.7 million (changed N/A YoY) and the FY2023 annual result came in at $52.7 million, changed N/A from the prior year.
- Goodwill & Intangibles steadied at $52.7 million in Q2 2023 per IXHL's latest filing, from $52.7 million in the prior quarter.
- Over the last five years, Goodwill & Intangibles for IXHL reached as high as $52.7 million in Q4 2022 and fell as low as $52.7 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 52.72 Mn |
| Dec 31, 2022 | 52.72 Mn |